Employee Voices

Gregory Perry
Chief Financial Officer, Novelion Therapeutics
The vision of the company is quite simple: it's to be a leader in rare disease.
Gregory Perry video still image

In This Section

Hear What They Say

At Novelion Therapeutics, and our subsidiary Aegerion Pharmaceuticals, we seek to develop new standards of care for individuals living with rare diseases. We depend on the commitment, ideas and actions of each individual employee to advance patient care and a create sustainable future for our organization.